Continuous glucose monitors are about to get more complicated

The Abbott Libre Duo received FDA clearance as the first 2-in-1 continuous glucose monitor, combining glucose sensing with insulin-delivery capabilities in a single wearable device. Its dual-function design signals a shift toward more integrated, complex diabetes management tools that merge monitoring and therapy.